Respiratory Syncytial Virus (RSV) vaccines from GSK and Pfizer will carry warnings for an increased risk of Guillain-Barré syndrome (GBS), the U.S. Food Drug Administration (FDA) said.
Sexually transmitted infections are on the rise among older adults, with rates of chlamydia, gonorrhea, and syphilis more than doubling in the United States...